Cargando…

Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach

Amitriptyline was first introduced as a medication to treat depression. Over time, this substance has been used to treat other conditions, such as gastrointestinal disorders, fibromyalgia, neuropathic pain, and analgesia, among others. However, there are no published studies that provide a broad vie...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Cristian dos Santos, Cruz, Jorddy Neves, Ferreira, Maria Karolina Martins, Baia-da-Silva, Daiane Claydes, Fontes-Junior, Eneas Andrade, Lima, Rafael Rodrigues
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386017/
https://www.ncbi.nlm.nih.gov/pubmed/37513958
http://dx.doi.org/10.3390/ph16071047
_version_ 1785081556326416384
author Pereira, Cristian dos Santos
Cruz, Jorddy Neves
Ferreira, Maria Karolina Martins
Baia-da-Silva, Daiane Claydes
Fontes-Junior, Eneas Andrade
Lima, Rafael Rodrigues
author_facet Pereira, Cristian dos Santos
Cruz, Jorddy Neves
Ferreira, Maria Karolina Martins
Baia-da-Silva, Daiane Claydes
Fontes-Junior, Eneas Andrade
Lima, Rafael Rodrigues
author_sort Pereira, Cristian dos Santos
collection PubMed
description Amitriptyline was first introduced as a medication to treat depression. Over time, this substance has been used to treat other conditions, such as gastrointestinal disorders, fibromyalgia, neuropathic pain, and analgesia, among others. However, there are no published studies that provide a broad view of the possible motivations that have led to changes in the use of amitriptyline. In this study, we have identified the landscape of use for amitriptyline based on knowledge mapping of the 100 most-cited articles about this drug. We searched Web of Science Core Collection without time and language restrictions. We obtained 14,446 results, but we only used the 100 most-cited articles that had amitriptyline as the object of study. We collected the following information from each article: authors, country of the corresponding authors, year of publication, citation count, citation density (number of citations per year), and keywords. In addition, we seek to map in the chosen articles study design and research findings. We found that since 1980, the use of amitriptyline has expanded beyond depression, moving to off-label use to treat a variety of diseases and conditions, including post-herpetic neuralgia, neuropathic pain, primary fibrosis, fibromyalgia, and migraine, can be considered a drug with more clinical applicability than its original clinical indication.
format Online
Article
Text
id pubmed-10386017
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103860172023-07-30 Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach Pereira, Cristian dos Santos Cruz, Jorddy Neves Ferreira, Maria Karolina Martins Baia-da-Silva, Daiane Claydes Fontes-Junior, Eneas Andrade Lima, Rafael Rodrigues Pharmaceuticals (Basel) Article Amitriptyline was first introduced as a medication to treat depression. Over time, this substance has been used to treat other conditions, such as gastrointestinal disorders, fibromyalgia, neuropathic pain, and analgesia, among others. However, there are no published studies that provide a broad view of the possible motivations that have led to changes in the use of amitriptyline. In this study, we have identified the landscape of use for amitriptyline based on knowledge mapping of the 100 most-cited articles about this drug. We searched Web of Science Core Collection without time and language restrictions. We obtained 14,446 results, but we only used the 100 most-cited articles that had amitriptyline as the object of study. We collected the following information from each article: authors, country of the corresponding authors, year of publication, citation count, citation density (number of citations per year), and keywords. In addition, we seek to map in the chosen articles study design and research findings. We found that since 1980, the use of amitriptyline has expanded beyond depression, moving to off-label use to treat a variety of diseases and conditions, including post-herpetic neuralgia, neuropathic pain, primary fibrosis, fibromyalgia, and migraine, can be considered a drug with more clinical applicability than its original clinical indication. MDPI 2023-07-24 /pmc/articles/PMC10386017/ /pubmed/37513958 http://dx.doi.org/10.3390/ph16071047 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pereira, Cristian dos Santos
Cruz, Jorddy Neves
Ferreira, Maria Karolina Martins
Baia-da-Silva, Daiane Claydes
Fontes-Junior, Eneas Andrade
Lima, Rafael Rodrigues
Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach
title Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach
title_full Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach
title_fullStr Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach
title_full_unstemmed Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach
title_short Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach
title_sort global research trends and hotspots analysis of the scientific production of amitriptyline: a bibliometric approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386017/
https://www.ncbi.nlm.nih.gov/pubmed/37513958
http://dx.doi.org/10.3390/ph16071047
work_keys_str_mv AT pereiracristiandossantos globalresearchtrendsandhotspotsanalysisofthescientificproductionofamitriptylineabibliometricapproach
AT cruzjorddyneves globalresearchtrendsandhotspotsanalysisofthescientificproductionofamitriptylineabibliometricapproach
AT ferreiramariakarolinamartins globalresearchtrendsandhotspotsanalysisofthescientificproductionofamitriptylineabibliometricapproach
AT baiadasilvadaianeclaydes globalresearchtrendsandhotspotsanalysisofthescientificproductionofamitriptylineabibliometricapproach
AT fontesjunioreneasandrade globalresearchtrendsandhotspotsanalysisofthescientificproductionofamitriptylineabibliometricapproach
AT limarafaelrodrigues globalresearchtrendsandhotspotsanalysisofthescientificproductionofamitriptylineabibliometricapproach